Peroxisome Proliferator Receptor alpha Agonist [EPC]: Side Effects & Safety Data for 4 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Peroxisome Proliferator Receptor alpha Agonist [EPC] includes 4 drugs with a combined 18,730 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
4
Drugs in Class
18,730
Combined Reports
All Peroxisome Proliferator Receptor alpha Agonist [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| PIOGLITAZONE | PIOGLITAZONE | 11,771 | 1,954 | 1,485 | 16.6% |
| FENOFIBRATE | Fenofibrate | 5,721 | 672 | 2,283 | 11.7% |
| GEMFIBROZIL | Gemfibrozil | 1,089 | 101 | 286 | 9.3% |
| FENOFIBRIC ACID | Fenofibric Acid | 149 | 19 | 32 | 12.8% |
Common Side Effects in Peroxisome Proliferator Receptor alpha Agonist [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Bladder cancer | 7,295 | 1,522 |
| Death | 1,049 | 1,049 |
| Drug hypersensitivity | 681 | 1 |
| Dyspnoea | 650 | 246 |
| Drug ineffective | 645 | 35 |
| Myalgia | 557 | 185 |
| Fatigue | 532 | 197 |
| Fall | 482 | 233 |
| Dizziness | 478 | 209 |
| Diarrhoea | 468 | 228 |